Archive for the ‘vaccines’ Category

French judges investigate vaccine manufacturer for manslaughter

Wednesday, March 19th, 2008

In what was called a “thunderclap in the vaccine industry,” French authorities have opened a formal investigation concerning a hepatitis B vaccination campaign by GlaxoSmithKline and Sanofi Pasteur in the 1990s. It is alleged that the companies failed to fully disclose neurologic side effects. Another investigation opened by Judge Marie-Odile Bertella-Geffroy concerns the death (“manslaughter”) of a 28-year-old woman from multiple sclerosis, allegedly connected to the vaccine (Le Figaro 1/31/08).

From 1994 to 1998, almost two-thirds of the French population and almost all newborn babies were vaccinated against hepatitis B, but the campaign was temporarily suspended because of concerns about side effects.

Some 30 plaintiffs, including the families of five patients who died after the vaccination, have launched civil actions (Reuters 1/1/08).

A British case-controlled analysis showed an odds ratio of 3.1 (95% CI 1.5-6.3) for first symptoms of multiple sclerosis in recipients of recombinant hepatitis B vaccine compared to controls. Two previous French studies had shown a RR of about 1.5. Other studies showed a nonsignificant increase or null findings, especially when date of diagnosis rather than date of first symptoms was used (Neurology 2004;63:838-842).

According to attorney Clifford Miller, “British doctors administering hepatitis B vaccine to infants could face criminal prosecution if fully informed consent is not obtained. Civil prosecution for damages is possible over 21 years later if the injured survive as adults” (UK Press Association Newswire/Romeike, September 2005).

The hepatitis B vaccine has been considered “one of the safest vaccines ever produced” (Neurology, op. cit.). On the other hand, French medical expert Marc Girard has said that “for a preventive measure, hepatitis B is remarkable for the frequency, variety and severity of complications from its use” (Romeike, op.cit.)

Additional information:

Vaccine compensation fund to pay award to autistic girl; broad implications feared

Monday, March 10th, 2008

Although an attorney representing the federal government said that it “has not conceded that vaccines cause autism,” Associated Press headlines read that “officials concede vaccines’ link to illness like autism” (AP 3/6/08). Petitioner Hannah Joling, now 9 years old, received 5 vaccines at once in 2000. According to a document that AP obtained from the U.S. Department of Health and Human Services, this aggravated an underlying mitochondrial disorder, causing metabolic dysfunction manifesting as worsened brain function with features of autistic spectrum disorder.

The document drew no conclusions as to the role of thimerosal. The government has previously denied any link at all between vaccine components and autism.

A Portuguese study suggested that 7% of autistic children might have a mitochondrial disorder, compared to 0.02% in the whole population.

Stories are conflicting about the time of onset of Hannah’s symptoms. Some state that she had suggestive symptoms at age 3 months; others that she was developing normally until the vaccines were given at 19 months. Her father Jon Poling, M.D., Ph.D., a neurologist, and mother, who is a lawyer and nurse, contend that the vaccines were also responsible for their daughter’s mitochondrial disorder (Kent Heckenlively, Age of Autism 3/5/08).

The family has filed a request with the court to unseal the documents on the case. A spokesman for the U.S. Department of Justice, which represents the government in all cases, refused to grant interviews or to explain to the Atlanta Journal-Constitution why it isn’t releasing the records (Alison Young, Atlanta Journal-Constitution 3/6/08).

The 5,000 families seeking compensation for autism or other developmental disorders they blame on vaccines are encouraged by the decision, the first of its type. However, each case needs to be proved on its own merits, and the decision is so narrowly worded that it may not be a helpful precedent.

Whatever the cause, the number of children receiving Supplemental Social Security Income (SSI) for disability has more than tripled in 20 years. In 1960, only 1.8% of U.S. children or adolescents were said by their parents to have a limitation of activity due to a health condition of more than 3 months’ duration; this rate had increased to more than 7% by 2004. Conditions include obesity, asthma (which has doubled since the 1980s), and attention-deficit/hyperactivity disorder (ADHD, affecting some 6% of schoolchildren).

Potential causative factors, according to JAMA, include maternal smoking (although its prevalence has decreased), poverty (which is stable), and “fast foods.” The only suggested role for the large increase in the number of vaccines is that less or less normal stimulation of the immune system, owing to less exposure to viral infections in early childhood, could cause greater susceptibility to allergens (JM Perrin, et al., JAMA 6/27/07).

There is also a significant increase in both type 1 and type 2 diabetes mellitus in children, at least partly attributed to obesity (RB Lipton, JAMA 6/26/07). Some wonder whether this too could have a link to vaccines. Hemophilus immunization has been associated with autoantibodies to islet cells. A Danish study recently showed an attributable risk of 2.3/100 (2.3%) of type 1 diabetes from hemophilus immunization in siblings of insulin-dependent diabetic children (JB Classen, Open Ped Med J 2/25/08).

Establishing the role of vaccines in any chronic, disabling condition could open floodgates of demand for compensation. And this single case of compensation for autism is making public health officials and pediatricians worry that parents will skip vaccinations.

A CDC panel voted unanimously to recommend influenza vaccine annually for all school-age children (WorldNetDaily 2/28/08). New Jersey officials have told parents that their babies can’t attend day care without their flu shot. Most influenza vaccine contains thimerosal.

Two other vaccine-court cases testing the alleged connection between thimerosal and autism go to trial in May.

Additional information: